From the Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School; the American Association for Accreditation of Ambulatory Surgery Facilities; and the Department of Plastic, Reconstructive and Hand Surgery, Radboud University Nijmegen Medical Centre.
Plast Reconstr Surg. 2018 Jul;142(1):90-98. doi: 10.1097/PRS.0000000000004499.
Concerns have arisen over reports of deaths occurring after certain outpatient plastic surgery procedures. Here, the authors present a national analysis, reporting on deaths occurring after outpatient cosmetic surgical procedures and venous thromboembolism screening.
A retrospective analysis of the American Association for Accreditation of Ambulatory Surgical Facilities database was performed for the years 2012 to 2017. The authors retrieved data for all deaths occurring in association with cosmetic plastic surgery procedures. Patient demographics, procedural data, venous thromboembolism risk factor assessment, and cause of death were analyzed. Deidentified medical records, including coroner's reports, were reviewed where available.
Data for 42 deaths were retrieved. Of these, 90.5 percent (n=38) were female, and 61.9 percent were Caucasian (n=26). Mean age was 51.6 years, while mean body mass index was 29.5 kg/m(2). Overall, 54.8 percent of these deaths occurred after abdominoplasty: 42.9 percent in isolation, 9.5 percent in combination with breast surgery, and 2.4 percent with facial surgery. Of the causes of death, most (38.1 percent) were thromboembolic in origin. Notably, in 25 of 42 cases, venous thromboembolism risk factor assessment was incorrect or absent (59.5 percent).
Accreditation agencies provide transparency and insight into outpatient surgical mortality on a national scale. Results suggest that adoption of venous thromboembolism screening techniques may not be universal despite an existing large body of published evidence. Optimization of thromboembolism prevention pathways remains vital, and consideration of anticoagulation in those undergoing abdominoplasty may be important in lowering outpatient mortality.
有报道称,某些门诊整形手术后会出现死亡,对此人们表示担忧。在这里,作者进行了一项全国性分析,报告了门诊美容手术和静脉血栓栓塞筛查后发生的死亡事件。
对 2012 年至 2017 年期间美国门诊手术设施认证协会数据库进行了回顾性分析。作者检索了与美容整形手术相关的所有死亡病例的数据。分析了患者人口统计学、手术数据、静脉血栓栓塞风险因素评估和死因。在有条件的情况下,审查了经过鉴定的医疗记录,包括验尸报告。
共检索到 42 例死亡病例。其中,90.5%(n=38)为女性,61.9%为白人(n=26)。平均年龄为 51.6 岁,平均体重指数为 29.5kg/m²。这些死亡病例中,54.8%发生在腹部整形术后:42.9%单独发生,9.5%与乳房手术联合发生,2.4%与面部手术联合发生。在死因中,大多数(38.1%)为血栓栓塞性。值得注意的是,在 42 例病例中,有 25 例(59.5%)静脉血栓栓塞风险因素评估不正确或缺失。
认证机构在全国范围内提供门诊手术死亡率的透明度和深入了解。结果表明,尽管有大量已发表的证据,但静脉血栓栓塞筛查技术的采用可能并不普遍。优化血栓栓塞预防途径仍然至关重要,考虑对接受腹部整形手术的患者进行抗凝治疗可能有助于降低门诊死亡率。